Neuren Pharmaceuticals | NEU - Interest Expense On Debt

Stock Price
12.79
Daily Change
-0.06 -0.47%
Monthly
2.48%
Yearly
-3.03%
Q2 Forecast
12.55

Neuren Pharmaceuticals reported AUD0 in Interest Expense on Debt for its fiscal semester ending in June of 2024.





Interest Expense On Debt Change Date
Akebia Therapeutics 362.52M 357.69M Mar/2026
Alaunos Therapeutics USD 1.07M 215K Jun/2023
Avita Medical AUD 1.25M 100K Jun/2025
Clinuvel Pharmaceuticals AUD 2.49M 51.97K Jun/2025
Dianthus Therapeutics USD 4.44M 263K Sep/2024
Genetic Signatures AUD 18K 17K Jun/2024
Ionis Pharmaceuticals USD 17M 1000K Mar/2026
Medical Developments International AUD 18K 3K Jun/2025
Neuren Pharmaceuticals AUD 0 0 Jun/2024
Organon & Co USD 128M 3M Sep/2025
Paradigm Biopharmaceuticals AUD 1000 3K Jun/2025
PYC Therapeutics AUD 17K 11K Jun/2025
Tectonic Therapeutic USD 246.58M 246.56M Mar/2026
Telix Pharmaceuticals AUD 7.62M 11.22M Dec/2025
Viatris USD 120.1M 500K Mar/2026
Xeris Pharmaceuticals USD 7.15M 115K Dec/2025